NCT06558045View on ClinicalTrials.gov

Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

July 18, 2023

Study Completion Date

October 2, 2023

Conditions
Healthy
Interventions
DRUG

Rivaroxaban 20 mg film-coated tablet

One tablet of the test drug was given orally 30 minutes after subjects have consumed a standardized high fat meal as breakfast

DRUG

Xarelto 20 mg film-coated tablet

One tablet of the reference drug was given orally 30 minutes after subjects have consumed a standardized high fat meal as breakfast

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

Dexa Medica Group
All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT06558045 - Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets | Biotech Hunter | Biotech Hunter